RACK ROOM SHOES, INC. – Trademark Portfolio
Entity Type: 03
RACK ROOM SHOES, INC. holds 45 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 25 (Clothing) — 34 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 4 Nice Classification classes. Currently, 12 trademarks are registered. Notable registered marks include MARIPE, BORELLI, BJORNDAL, FABULAIRE, and KIDS FEET. The owner is based in SALISBURY, NC.
118 S. MAIN STREET
SALISBURY, NC 28144
Showing of trademarks Trademarks
Trademark Classifications
RACK ROOM SHOES, INC.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Scientific and technological services; industrial analysis and research services
Leather and imitations of leather; animal skins, hides; trunks and travelling bags
Frequently Asked Questions
How many trademarks does RACK ROOM SHOES, INC. have?
RACK ROOM SHOES, INC. has 45 U.S. trademarks filed with the USPTO. Of these, 12 registered, 25 abandoned, 8 cancelled.
What trademark classes does RACK ROOM SHOES, INC. file in?
RACK ROOM SHOES, INC. files trademarks across 4 Nice Classification classes. The most active classes are Class 25 (Clothing), Class 35 (Advertising & Business), Class 42 (Computer & Scientific), Class 18 (Leather Goods). Class 25 covers clothing, footwear, headgear.
What are RACK ROOM SHOES, INC.'s most well-known trademarks?
RACK ROOM SHOES, INC.'s registered trademark portfolio includes well-known marks such as MARIPE, BORELLI, BJORNDAL, FABULAIRE, and KIDS FEET. These are among 12 currently registered trademarks in the portfolio.
What is RACK ROOM SHOES, INC.'s trademark registration success rate?
RACK ROOM SHOES, INC. has a 27% trademark registration rate, with 12 out of 45 resolved applications resulting in successful registration. Currently, 0 applications are pending review.